RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | RNA Virus Infections |
|
Accession: | DOID:9002150
|
browse the term
|
Definition: | Diseases caused by RNA VIRUSES. |
Synonyms: | exact_synonym: | RNA Virus Infection |
| primary_id: | MESH:D012327 |
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
treatment |
ISO |
DNA:haplotype: :3435T>C((rs1045642), 2677T>G (rs2032582) (human) DNA:SNP: : rs10276036(human) |
RGD |
PMID:23372834 PMID:24517233 |
RGD:39456119, RGD:11098698 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
ISO |
DNA:SNPs: : |
RGD |
PMID:26885809 |
RGD:14398494 |
NCBI chr16:18,217,404...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
DNA:SNP:3' utr:rs1719153 (human) |
RGD |
PMID:16773571 |
RGD:5683896 |
NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, delayed progression to |
ClinVar |
PMID:9742978 PMID:12610055 PMID:12815099 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd209d |
CD209d molecule |
disease_progression |
ISO |
associated with factor VIII deficiency; DNA:SNP:promoter: g.-139C>T (rs2287886) (human) |
RGD |
PMID:17530998 |
RGD:39939010 |
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:9499800 |
RGD:11344976 |
NCBI chr X:135,127,119...135,138,302
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
susceptibility |
ISO |
DNA:polymorphism:exon:p.K751Q(human) |
RGD |
PMID:20127180 |
RGD:5688740 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
associated with pulmonary tuberculosis;protein:increased expression:blood (human) |
RGD |
PMID:32369456 |
RGD:39939073 |
NCBI chr16:67,430,684...67,442,459
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifna1 |
interferon, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9612607 |
|
NCBI chr 5:103,095,767...103,098,260
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, rapid progression to |
CTD ClinVar |
PMID:9612607 PMID:12854077 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:11232005 |
RGD:5509969 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:9861562 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, slow progression to |
ClinVar |
PMID:2278997 PMID:2307934 PMID:9620765 PMID:15712015 PMID:16189667 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Kir3dl1 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 |
severity |
ISO |
DNA:missense mutation:cds: p.I47V (rs643347) (human) |
RGD |
PMID:29461980 |
RGD:38676267 |
NCBI chr 1:69,715,529...69,754,050
Ensembl chr 1:69,715,535...69,754,050
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:27382604 |
RGD:40818276 |
NCBI chr 1:69,614,744...69,622,570
|
|
G |
Ncr3 |
natural cytotoxicity triggering receptor 3 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:27382604 |
RGD:40818276 |
NCBI chr20:3,637,242...3,643,748
Ensembl chr20:3,638,240...3,643,799
|
|
G |
RT1-CE15 |
RT1 class I, locus CE15 |
susceptibility |
ISO |
DNA:polymorphism: :HLA-A31 |
RGD |
PMID:19030725 |
RGD:36049809 |
NCBI chr20:3,276,054...3,279,059
Ensembl chr20:3,264,172...3,279,563
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
susceptibility |
ISO |
DNA:polymorphism: :HLA-A31 |
RGD |
PMID:19030725 |
RGD:36049809 |
NCBI chr20:3,257,752...3,260,683
Ensembl chr20:3,257,123...3,279,563
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27400929 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:20818790 |
RGD:10395393 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
associated with HIV Infections;protein:increased expression:cerebrospinal fluid: |
RGD |
PMID:17929958 |
RGD:5509882 |
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP |
protein:increased expression:neocortex |
RGD |
PMID:17678975 |
RGD:1626641 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Insr |
insulin receptor |
severity |
ISO |
protein:increased expression:cerebrospinal fluid, plasma |
RGD |
PMID:22629383 |
RGD:10403033 |
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Irs1 |
insulin receptor substrate 1 |
severity |
ISO |
protein:decreased tyrosine phosphorylation:cerebrospinal fluid, leukocyte |
RGD |
PMID:22629383 |
RGD:10403033 |
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
associated with HIV Seropositivity;protein:increased expression:plasma, CSF (human) protein:increased expression:CSF (human) |
RGD |
PMID:30105502 PMID:27400930 |
RGD:127284876, RGD:127284885 |
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Npy |
neuropeptide Y |
severity |
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:8815163 |
RGD:10431910 |
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27400929 |
|
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
|
RGD |
PMID:21368226 |
RGD:6482787 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
|
RGD |
PMID:25404050 |
RGD:38676266 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
|
RGD |
PMID:2 |
RGD:1303381 |
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
|
RGD |
PMID:2 |
RGD:1303381 |
NCBI chr X:112,119,673...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
|
RGD |
PMID:19357719 |
RGD:6906909 |
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Hp |
haptoglobin |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:19279121 |
RGD:11041816 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:23678040 PMID:23678040 |
RGD:7245474, RGD:7245474 |
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
protein:decreased expression:glomerulus |
RGD |
PMID:22313957 |
RGD:6903274 |
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Notch4 |
notch receptor 4 |
|
IEP |
protein: increased expression: kidney |
RGD |
PMID:20706108 |
RGD:6480788 |
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
treatment |
ISO |
|
RGD |
PMID:19188342 PMID:17229913 |
RGD:38596324, RGD:38599164 |
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
treatment |
ISO |
|
RGD |
PMID:23018378 |
RGD:39018554 |
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
|
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10861090 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
|
G |
Cd4 |
Cd4 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9546790 |
|
NCBI chr 4:157,668,878...157,695,366
|
|
G |
Tnfrsf8 |
TNF receptor superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9379333 |
|
NCBI chr 5:157,123,183...157,168,421
Ensembl chr 5:157,123,185...157,168,421
|
|
|
G |
Aicda |
activation-induced cytidine deaminase |
severity |
ISO |
|
RGD |
PMID:29321331 |
RGD:127285644 |
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
|
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
|
RGD |
PMID:21641396 |
RGD:126779561 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Cd1d1 |
CD1d1 molecule |
|
ISO |
|
RGD |
PMID:32153566 |
RGD:127345122 |
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
|
RGD |
PMID:21423809 |
RGD:127285543 |
NCBI chr 2:120,119,598...120,126,941
Ensembl chr 2:120,119,444...120,126,996
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
mRNA, protein:increased expression:spleen (mouse) |
RGD |
PMID:29593047 |
RGD:126790521 |
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
|
RGD |
PMID:11927625 |
RGD:150340679 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
ameliorates |
ISO |
|
RGD |
PMID:15723812 |
RGD:41789630 |
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17287727 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
severity treatment |
ISO |
human protein in a mouse model |
RGD |
PMID:24800825 PMID:24800825 |
RGD:32716391, RGD:32716391 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
susceptibility |
ISO |
CTD Direct Evidence: therapeutic human gene in a mouse model |
CTD RGD |
PMID:178595 PMID:28396461 |
RGD:126777675 |
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:18613795 |
RGD:5135502 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:28423682 |
RGD:127229942 |
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
|
G |
Rhob |
ras homolog family member B |
|
IDA |
|
RGD |
PMID:1710770 |
RGD:704375 |
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
|
IEP |
mRNA, protein:decreased expression:cerebellum, Purkinje cell |
RGD |
PMID:17182680 |
RGD:2301132 |
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Atf4 |
activating transcription factor 4 |
|
IEP |
protein:increased expression:cerebellum |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
|
IEP |
protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
IEP |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
IEP |
mRNA,protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
IEP |
protein:increased expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
IEP |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb6 |
gap junction protein, beta 6 |
|
IEP |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chr15:31,284,562...31,295,010
Ensembl chr15:31,284,419...31,294,582
|
|
G |
Il16 |
interleukin 16 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:14698845 |
RGD:1354526 |
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
protein:increased expression:astrocyte |
RGD |
PMID:11870869 |
RGD:1642006 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mt3 |
metallothionein 3 |
|
IEP |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
IEP |
mRNA:decreased expression:hippocampus |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
IEP |
mRNA,protein:increased expression,increased activity:neuron, glial cell: |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
S100b |
S100 calcium binding protein B |
|
IEP |
protein:decreased expression:cerebellum, cerebral cortex |
RGD |
PMID:17376896 |
RGD:5508841 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IEP |
protein:increased expression:brain (rat) |
RGD |
PMID:12106671 |
RGD:38549588 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Xbp1 |
X-box binding protein 1 |
|
IEP |
mRNA,protein:altered expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
exacerbates |
ISO |
|
RGD |
PMID:30814285 |
RGD:41789623 |
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
|
G |
Fut2 |
fucosyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12692541 |
|
NCBI chr 1:96,119,549...96,139,567
Ensembl chr 1:96,119,371...96,140,360
|
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
ISO |
encephalomyocarditis virus;mRNA, protein:decreased expression, increased expression:heart (mouse) |
RGD |
PMID:19453650 |
RGD:40818405 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
ISO |
|
RGD |
PMID:21636578 |
RGD:40902809 |
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
susceptibility |
IMP |
|
RGD |
PMID:27999109 PMID:27999109 |
RGD:12910492, RGD:12910492 |
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
|
|
G |
Ifnar1em1 |
interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1 |
|
IMP |
|
RGD |
PMID:27999109 |
RGD:12910492 |
|
|
G |
Ifnar1em2 |
interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2 |
|
IMP |
|
RGD |
PMID:27999109 |
RGD:12910492 |
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
mRNA:increased expression:brain: |
RGD |
PMID:18552204 |
RGD:40400716 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Pde12 |
phosphodiesterase 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26055709 |
|
NCBI chr16:1,915,386...1,925,427
Ensembl chr16:1,915,386...1,925,887
|
|
G |
Rnasel |
ribonuclease L |
|
ISO |
|
RGD |
PMID:21636578 |
RGD:40902809 |
NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10609881 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
ISO |
|
RGD |
PMID:25053563 |
RGD:14398493 |
NCBI chr16:18,217,404...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
DNA:polymorphism:cds: HLA-DQB1*03:03 (human) |
RGD |
PMID:23710940 |
RGD:36049872 |
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
severity |
ISO |
DNA:SNP:introns:(rs3890182, rs1883025) (human) |
RGD |
PMID:28164591 |
RGD:21066337 |
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
susceptibility treatment disease_progression |
ISO |
DNA:SNP:cds:1331T>C, p.V444A,(rs2287622)(human) DNA:SNP:cds:c.1331T>C (rs2287622)(human) |
RGD |
PMID:29755014 PMID:29091211 PMID:22681771 |
RGD:14402415, RGD:14402417, RGD:14402416 |
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility treatment |
ISO |
DNA:SNP::2677G>T/A(rs2032582)(human) DNA:SNP: :3435C>T(human) |
RGD |
PMID:26922556 PMID:29155127 |
RGD:11574565, RGD:14700907 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ace |
angiotensin I converting enzyme |
treatment |
ISO IEP |
protein:decreased expression:serum (human) |
RGD |
PMID:29641775 PMID:17106926 PMID:27147779 |
RGD:25671451, RGD:40400711, RGD:25671456 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Adar |
adenosine deaminase, RNA-specific |
no_association disease_progression treatment |
ISO |
DNA:SNP:exon: (rs1127309) (human) associated with human immunodeficiency virus infectious disease;DNA:missense mutation:exon 2, 3' utr:p.K384R (rs2229857, rs1127326) (human) DNA:silent mutation:CDS:p.V849V (rs1127309) (human) DNA:snps, haplotype: (rs7515339, rs903323) (human) |
RGD |
PMID:26911666 PMID:29906476 PMID:19434718 PMID:17979507 |
RGD:11554370, RGD:125097514, RGD:125097513, RGD:38599150 |
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:26293833 |
RGD:14401718 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Aicda |
activation-induced cytidine deaminase |
disease_progression |
ISO |
mRNA:increased expression:B cell mRNA, protein:increased expression:B cell, CD19-positive (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:26219420 PMID:20189883 PMID:26946048 |
RGD:30296664, RGD:32716380, RGD:32716369 |
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
|
|
G |
Ang |
angiogenin |
|
ISO |
|
RGD |
PMID:21848603 |
RGD:6892709 |
NCBI chr15:24,317,733...24,323,361
|
|
G |
Apoe |
apolipoprotein E |
severity |
ISO |
DNA:polymorphism:exon: |
RGD |
PMID:12143056 |
RGD:7495764 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Aurka |
aurora kinase A |
|
ISO |
mRNA:increased expression:CD19+Bcell: |
RGD |
PMID:20189883 |
RGD:32716380 |
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
RNA:increased expression:liver: |
RGD |
PMID:24429361 |
RGD:14975280 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
severity treatment disease_progression |
ISO |
DNA:polymorphism:promoter:-403G>A(human) DNA:SNPs,haplotype: : mRNA:increased expression:liver: DNA:SNP: :rs3817656(human) |
RGD |
PMID:12557141 PMID:15368437 PMID:15770052 PMID:29703961 |
RGD:14995332, RGD:14995340, RGD:14995336, RGD:14995334 |
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
mRNA:increased expression:CD19+Bcell: |
RGD |
PMID:20189883 |
RGD:32716380 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
mRNA:increased expression:CD19+Bcell: |
RGD |
PMID:20189883 |
RGD:32716380 |
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
disease_progression treatment |
ISO |
DNA:deletion:cds: |
RGD |
PMID:12055576 PMID:12873822 |
RGD:14401729, RGD:14401737 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd163 |
CD163 molecule |
exacerbates |
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:26554542 |
RGD:149735574 |
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd209d |
CD209d molecule |
|
ISO |
DNA:SNPs,haplotypes:promoter: -939G>A, -871A>G (human) |
RGD |
PMID:27348632 |
RGD:39939007 |
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Cd226 |
CD226 molecule |
treatment |
ISO |
|
RGD |
PMID:21695691 |
RGD:40818295 |
NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
protein:increased expression:peripheral blood mononuclear cell |
RGD |
PMID:18086898 |
RGD:41410796 |
NCBI chr 1:227,116,627...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cldn1 |
claudin 1 |
susceptibility |
ISO IEP |
associated with intravenous substance abuse;DNA:SNP:promoter, intron:multiple mutations mRNA:decreased expression:liver (human) |
RGD |
PMID:19674288 PMID:21412800 |
RGD:25330352, RGD:26884350 |
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Clec4m |
C-type lectin domain family 4 member M |
disease_progression |
ISO |
DNA:polymorphism,repeats:exon4: allele 4 (human) |
RGD |
PMID:24283933 |
RGD:41410818 |
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
|
ISO |
mRNA, protein:decreased expression:liver hepatocytes (human) |
RGD |
PMID:15685545 |
RGD:5683635 |
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Crp |
C-reactive protein |
|
ISO |
|
RGD |
PMID:22333691 |
RGD:6482311 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
treatment |
ISO |
DNA:SNP,haplotype:exon,promoter:49A>G,-318 T>C(human) |
RGD |
PMID:12696006 |
RGD:14398739 |
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:31127759 |
RGD:27095949 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
severity |
ISO |
DNA:polymorphism:promoter: 1260C>A (rs10877012) (human) |
RGD |
PMID:21145801 |
RGD:25671413 |
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:10435724 |
RGD:11353781 |
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
|
RGD |
PMID:18673437 |
RGD:38548921 |
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
severity |
ISO |
|
RGD |
PMID:10934805 |
RGD:14747019 |
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased activity:plasma |
RGD |
PMID:22922605 |
RGD:14975251 |
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
ISO |
protein:increased activity:plasma |
RGD |
PMID:22922605 |
RGD:14975251 |
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:17397002 |
RGD:14700966 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
|
RGD |
PMID:17397002 |
RGD:14700966 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hp |
haptoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16597321 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
mRNA, protein:increased expression, increased activity:monocytes,myeloid dendritic cells,serum (human) |
RGD |
PMID:25605587 |
RGD:39939081 |
NCBI chr16:67,430,684...67,442,459
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifna2 |
interferon alpha 2 |
treatment |
ISO |
associated with end stage renal disease |
RGD |
PMID:9187562 PMID:7493300 PMID:19152412 PMID:21272456 PMID:8868074 PMID:17881538 PMID:9310930 More...
|
RGD:40886308, RGD:40886318, RGD:40886316, RGD:40886314, RGD:40886313, RGD:40886311, RGD:40886310 |
NCBI chr 5:103,258,617...103,259,195
|
|
G |
Ifnl1 |
interferon, lambda 1 |
ameliorates |
ISO |
protein:increased expression:blood serum (human) mRNA,protein:increased expression:liver, blood serum (human) protein:altered expression:blood serum (human) |
RGD |
PMID:30926417 PMID:23071503 PMID:21145813 |
RGD:126848741, RGD:126848749, RGD:126848747 |
NCBI chr 1:83,798,651...83,800,297
Ensembl chr 1:83,798,703...83,800,235
|
|
G |
Ifnl3 |
interferon, lambda 3 |
treatment disease_progression susceptibility |
ISO |
DNA:SNP: :rs8099917 (human) DNA:SNP:enhancer: (rs8099917) (human) DNA:SNP,haplotype:enhancer: (rs12979860,rs8099917) (human) DNA:SNP:enhancer: (rs12979860) (human) DNA:SNP:enhancer: (rs12979860,rs8099917) (human) DNA:SNP:5'utr: (rs12979860) (human) DNA:SNPs:3'utr, enhancer: (rs12980275, rs12979860) (human) DNA:SNP:3' utr: (rs4803217) (human) associated with Hemoglobinopathies;DNA:missense mutation, enhancer, haplotype:cds, :p.K70R, (rs12979860) (human) |
RGD |
PMID:23730840 PMID:24355007 PMID:24646752 PMID:28186161 PMID:26741362 PMID:24376784 PMID:27027531 PMID:25283962 PMID:28739427 PMID:25788203 PMID:28638221 PMID:21615377 More...
|
RGD:10766476, RGD:11096670, RGD:40886292, RGD:40886290, RGD:11344289, RGD:40886281, RGD:40886277, RGD:40822824, RGD:40400891, RGD:14398733, RGD:14398740, RGD:11528556 |
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Igf2 |
insulin-like growth factor 2 |
severity |
ISO |
DNA:SNPs, haplotype:multiple |
RGD |
PMID:16750516 |
RGD:14401723 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Il10 |
interleukin 10 |
treatment no_association susceptibility |
ISO |
protein:increased expression:serum: DNA:SNP:promoter: rs3021094, rs3024498 (human) DNA:SNP:promoter:-592C>A (rs1800872) (human) DNA:polymorphism:promoter: |
RGD |
PMID:26095186 PMID:25708446 PMID:29247709 PMID:29247709 PMID:26095186 |
RGD:14700655, RGD:38456002, RGD:14975141, RGD:14975141, RGD:14700655 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
severity |
ISO |
DNA:SNP:3' utr:+1188A>C (human) |
RGD |
PMID:15871664 |
RGD:14401721 |
NCBI chr10:28,888,832...28,903,796
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il17d |
interleukin 17D |
severity |
ISO |
associated with human immunodeficiency virus infectious disease;mRNA:increased expression:blood plasma (human) |
RGD |
PMID:27875997 |
RGD:40903073 |
NCBI chr15:31,665,795...31,688,840
|
|
G |
Il18 |
interleukin 18 |
treatment disease_progression |
ISO |
DNA:SNP:promoter:-607C>A (rs1946518)(human) |
RGD |
PMID:25198668 PMID:19740312 |
RGD:14696651, RGD:14696656 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il2 |
interleukin 2 |
treatment |
ISO |
|
RGD |
PMID:12673448 |
RGD:14807336 |
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il21 |
interleukin 21 |
ameliorates |
ISO |
protein:increased expression:liver, blood, CD4-positive, alpha-beta T cell (human) |
RGD |
PMID:24170093 |
RGD:127285373 |
NCBI chr 2:120,119,598...120,126,941
Ensembl chr 2:120,119,444...120,126,996
|
|
G |
Il27 |
interleukin 27 |
ameliorates |
ISO |
DNA:SNP:promoter:-964A>G (rs153109) (human) |
RGD |
PMID:27221901 |
RGD:126790538 |
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
DNA:SNPs:promoter:-590C>T,-33T>C (human) associated with factor VIII deficiency;protein:increased expression:serum: |
RGD |
PMID:22594992 PMID:25708446 PMID:23591975 |
RGD:14696678, RGD:38456002, RGD:14696686 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO |
DNA:SNPs:promoter:rs1800795 (human) |
RGD |
PMID:27812403 |
RGD:14975294 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
treatment |
ISO |
|
RGD |
PMID:28036111 |
RGD:40400915 |
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itgb6 |
integrin subunit beta 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18221819 |
|
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
|
|
G |
Kir3dl1 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 |
severity |
ISO |
protein:decreased expression:peripheral blood mono-nuclear cell, natural killer cell (human) |
RGD |
PMID:19470388 PMID:27239111 |
RGD:38676473, RGD:38676476 |
NCBI chr 1:69,715,529...69,754,050
Ensembl chr 1:69,715,535...69,754,050
|
|
G |
Klrc1 |
killer cell lectin like receptor C1 |
treatment |
ISO |
protein:increased expression:peripheral blood mononuclear cell, natural killer cell (human) |
RGD |
PMID:16322112 PMID:31218578 PMID:20550548 |
RGD:40818296, RGD:40400920, RGD:40818079 |
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
treatment disease_progression |
ISO |
protein:decreased expression:liver,natural killer cell (human) protein:increased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:25965701 PMID:25148254 PMID:21168454 |
RGD:39018562, RGD:40813739, RGD:40400738 |
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
|
|
G |
Krt18 |
keratin 18 |
disease_progression severity |
ISO |
protein:increased expression:serum (human) protein:increased expression:liver, serum (human) protein:increased degradation:serum (human) |
RGD |
PMID:30839434 PMID:23820504 PMID:22404726 PMID:19333204 |
RGD:18337481, RGD:18337500, RGD:18337496, RGD:18337493 |
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
protein:increased phosphorylation:liver (human) |
RGD |
PMID:15368451 |
RGD:14401583 |
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lep |
leptin |
|
IEP |
protein:altered localization:serum (human) |
RGD |
PMID:11336170 |
RGD:21201249 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
|
ISO |
mRNA:altered exression:PBMC,liver |
RGD |
PMID:17060687 |
RGD:21079470 |
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
mRNA:increased expression:CD19+Bcell: |
RGD |
PMID:20189883 |
RGD:32716380 |
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Mbl2 |
mannose binding lectin 2 |
treatment |
ISO |
DNA:SNPs:promoter,exon: DNA:haplotype:promoter, exon: |
RGD |
PMID:18336595 PMID:25956563 |
RGD:14696820, RGD:11076743 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mir107 |
microRNA 107 |
|
ISO |
RNA:decreased expression:liver: |
RGD |
PMID:24429361 |
RGD:14975280 |
NCBI chr 1:232,337,767...232,337,853
Ensembl chr 1:232,337,767...232,337,853
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:24895202 |
RGD:14401602 |
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir146a |
microRNA 146a |
|
ISO |
miRNA:increased expression:liver (human) miRNA:increased expression:peripheral blood mononuclear cell (mouse) |
RGD |
PMID:27147737 PMID:25877355 |
RGD:126925147, RGD:126925186 |
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:serum associated with rheumatoid arthritis |
RGD |
PMID:30852102 PMID:29575671 |
RGD:21079478, RGD:21403686 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir223 |
microRNA 223 |
treatment |
ISO |
|
RGD |
PMID:28864162 |
RGD:21408567 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
treatment exacerbates |
IEP ISO |
DNA:SNPs:promoter:g.-123C>A, -88G>T(human) DNA:SNPs:promoter: (rs2071430, rs17000900) (human) |
RGD |
PMID:28036111 PMID:25239021 PMID:29271328 |
RGD:40400915, RGD:11067846, RGD:126777679 |
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
treatment disease_progression |
ISO |
protein:decreased expression:peripheral blood mononuclear cell, natural killer cell (human) protein:increased expression:peripheral blood mononuclear cell, natural killer cell (human) protein:decreased expression:liver, natural killer cell (human) |
RGD |
PMID:31218578 PMID:23813131 PMID:16322112 PMID:21695691 PMID:20550548 PMID:25148254 PMID:21168454 More...
|
RGD:40400920, RGD:40818297, RGD:40818296, RGD:40818295, RGD:40818079, RGD:40813739, RGD:40400738 |
NCBI chr 1:69,614,744...69,622,570
|
|
G |
Ncr3 |
natural cytotoxicity triggering receptor 3 |
disease_progression treatment |
ISO |
protein:decreased expression:peripheral blood mononuclear cell, natural killer cell (human) protein:increased expression:peripheral blood mononuclear cell, natural killer cell (human) |
RGD |
PMID:21168454 PMID:23813131 PMID:16322112 PMID:21695691 PMID:20550548 |
RGD:40400738, RGD:40818297, RGD:40818296, RGD:40818295, RGD:40818079 |
NCBI chr20:3,637,242...3,643,748
Ensembl chr20:3,638,240...3,643,799
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
disease_progression |
ISO |
DNA:insertion:promoter: -94insATTG (rs28362491) (human) |
RGD |
PMID:26827631 |
RGD:11572306 |
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
|
RGD |
PMID:19628656 |
RGD:6483809 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO IEP |
mRNA, protein:decreased expression:liver hepatocytes (human) associated with liver cirrhosis;mRNA, protein:decreased expression:liver (human) |
RGD |
PMID:15685545 PMID:15685545 |
RGD:5683635, RGD:5683635 |
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Prdx5 |
peroxiredoxin 5 |
|
ISO |
mRNA:decreased expression:liver, blood (human) |
RGD |
PMID:32103340 |
RGD:41404682 |
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Prf1 |
perforin 1 |
disease_progression |
ISO |
protein:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:25148254 |
RGD:40813739 |
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphism: :HLA DQA1*03(human) DNA:polymorphism:haplotype: |
RGD |
PMID:8938158 PMID:9537846 |
RGD:14398842, RGD:14401559 |
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
disease_progression |
ISO |
DNA:polymorphism:cds:HLA-DQB1*02 (human) |
RGD |
PMID:17489060 |
RGD:36174022 |
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
disease_progression |
ISO |
DNA:polymorphism (human) DNA:polymorphisms:cds:HLA-DRB1*030101, DRB1*0701(human) |
RGD |
PMID:18925312 PMID:17489060 |
RGD:5147618, RGD:36174022 |
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
RT1-Ha |
RT1 class II, locus Ha |
disease_progression |
ISO |
DNA:SNP, haplotype: :rs3077, rs9277534(human) |
RGD |
PMID:24897020 |
RGD:14694819 |
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
|
|
G |
RT1-Hb-ps1 |
RT1 class II, locus Hb, pseudogene 1 |
ameliorates |
ISO |
mRNA:increased expression:peripheral blood mononuclear cell(human) DNA:polymorphism: :HLA-DPB1*04:01 (human) |
RGD |
PMID:27601657 PMID:28332201 |
RGD:150429796 RGD:150429805 |
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
disease_progression |
ISO |
DNA:polymorphisms, haplotype:promoter (human) |
RGD |
PMID:14960532 |
RGD:5684961 |
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
susceptibility |
ISO |
associated with alexithymia;DNA:haplotypes, multiple: |
RGD |
PMID:26609890 |
RGD:11352995 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:29924446 |
RGD:21066342 |
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
treatment |
ISO |
DNA:SNPs:promoter:-443C>T, -1748G>A (human) |
RGD |
PMID:15868370 |
RGD:1581374 |
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
severity |
ISO |
|
RGD |
PMID:17318196 |
RGD:8694293 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tlr3 |
toll-like receptor 3 |
treatment severity disease_progression susceptibility |
ISO |
DNA:SNP:cds:p.Leu412Phe(human) DNA:SNP: :rs13126816 (human) DNA:SNP: :rs3775290(human) treatment:peginterferon plus ribavirin. |
RGD |
PMID:23240626 PMID:28480979 PMID:23220997 PMID:29860675 PMID:30321082 PMID:19674283 More...
|
RGD:21079422, RGD:21079435, RGD:21079430, RGD:21079428, RGD:21079427, RGD:21079423 |
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tlr4 |
toll-like receptor 4 |
susceptibility |
ISO |
DNA:SNP: :rs2148356(human) protein:increased expression:serum: |
RGD |
PMID:26095186 PMID:26095186 |
RGD:14700655, RGD:14700655 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr9 |
toll-like receptor 9 |
severity |
ISO |
mRNA, protein:decreased expression:peripheral blood mononuclear cell (human) protein:increased expression:liver, peripheral blood mononuclear cell (human) |
RGD |
PMID:19513613 PMID:23026026 |
RGD:18337470, RGD:18337477 |
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
treatment severity |
ISO |
protein:increased expression:serum (human) protein:increased expression:plasma (human) |
RGD |
PMID:9047083 PMID:25708446 PMID:9440625 |
RGD:14995307, RGD:38456002, RGD:14995439 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
treatment |
ISO |
|
RGD |
PMID:21152182 |
RGD:8661764 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Usp18 |
ubiquitin specific peptidase 18 |
treatment |
ISO |
|
RGD |
PMID:28036111 |
RGD:40400915 |
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
|
|
G |
Vdr |
vitamin D receptor |
treatment no_association |
ISO |
DNA:polymorphism: : |
RGD |
PMID:27263300 PMID:26725771 |
RGD:14401746, RGD:14401749 |
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility |
ISO |
DNA:missense mutation:cds:p.R194W, p.R280H, p.R399Q (human) |
RGD |
PMID:29935355 |
RGD:15036797 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Zc3h12a |
zinc finger CCCH type containing 12A |
severity |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:21739451 PMID:25225661 |
RGD:39938976, RGD:39938960 |
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell |
RGD |
PMID:20395558 |
RGD:4145446 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15764644 |
RGD:5135489 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell |
RGD |
PMID:20395558 |
RGD:4145446 |
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
associated with Asthma |
RGD |
PMID:12751040 |
RGD:5135264 |
NCBI chr14:17,310,089...17,312,303
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19864593 |
RGD:5131210 |
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Defb4 |
defensin beta 4 |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus |
RGD |
PMID:15034083 |
RGD:4892264 |
NCBI chr16:70,650,472...70,653,665
Ensembl chr16:70,650,472...70,653,665
|
|
G |
Defb5 |
defensin beta 5 |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus |
RGD |
PMID:15034083 |
RGD:4892264 |
NCBI chr16:70,613,200...70,615,360
Ensembl chr16:70,613,146...70,615,467
|
|
G |
Ifna2 |
interferon alpha 2 |
treatment |
ISO |
|
RGD |
PMID:6381610 |
RGD:40886344 |
NCBI chr 5:103,258,617...103,259,195
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 |
RGD:4143183 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7734976 |
RGD:7401200 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:18279051 PMID:10358201 |
RGD:4143207, RGD:4143183 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion |
RGD |
PMID:20644177 |
RGD:4140459 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Prdx5 |
peroxiredoxin 5 |
|
ISO |
associated with asthma;protein:increased expression:sputum (human) |
RGD |
PMID:18219526 |
RGD:41404684 |
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Tslp |
thymic stromal lymphopoietin |
|
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV |
ClinVar |
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
|
ISO |
|
RGD |
PMID:18094157 |
RGD:38676499 |
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
Severe Acute Respiratory Syndrome |
RGD |
PMID:17108019 |
RGD:4140930 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14647384 PMID:16007097 PMID:19453650 PMID:19625462 PMID:22496216 PMID:23678171 PMID:24172901 PMID:24227843 PMID:25187545 More...
|
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20484496 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
|
RGD |
PMID:19906920 |
RGD:4891446 |
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO ISS |
Respiratory Syndrome, Severe Acute; mRNA:increased expression:lung (mouse) |
MouseDO RGD |
PMID:19906920 PMID:11543653 |
RGD:4891446, RGD:14401732 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd209c |
CD209c molecule |
|
ISO |
|
RGD |
PMID:20864747 |
RGD:5131184 |
NCBI chr12:1,936,233...1,943,841
Ensembl chr12:1,936,396...1,942,040
|
|
G |
Cd209d |
CD209d molecule |
|
ISO |
|
RGD |
PMID:20864747 |
RGD:5131184 |
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Ctsl |
cathepsin L |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081529 PMID:23678171 PMID:27733646 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:19626487 PMID:19906920 |
RGD:27095957, RGD:4891446 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
|
RGD |
PMID:17804032 |
RGD:5135236 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
IEP |
|
RGD |
PMID:17804032 |
RGD:5135236 |
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30626688 |
|
NCBI chr 3:46,962,243...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISS |
|
MouseDO |
|
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ifnb1 |
interferon beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24323636 |
|
NCBI chr 5:103,020,969...103,021,523
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
|
ISO |
|
RGD |
PMID:19906920 |
RGD:4891446 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
|
RGD |
PMID:28493345 |
RGD:14975163 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:19906920 |
RGD:4891446 |
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
|
RGD |
PMID:19906920 |
RGD:4891446 |
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
Severe Acute Respiratory Syndrome;protein:increased expression:lung |
RGD |
PMID:19906920 |
RGD:4891446 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20484496 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20484496 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
Severe Acute Respiratory Syndrome; DNA:mutations:5' utr, exon:g.-221G>C, p.G54N (human) |
RGD |
PMID:15838797 |
RGD:4889467 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
ISS |
|
MouseDO |
|
|
NCBI chr11:68,008,245...68,053,229
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISS |
|
MouseDO |
|
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Pi4kb |
phosphatidylinositol 4-kinase beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22253445 |
|
NCBI chr 2:182,540,377...182,572,684
Ensembl chr 2:182,540,567...182,588,488
|
|
G |
Ppp1r14c |
protein phosphatase 1, regulatory (inhibitor) subunit 14c |
|
ISS |
|
MouseDO |
|
|
NCBI chr 1:39,773,403...39,886,970
Ensembl chr 1:39,773,403...39,886,956
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISS |
|
MouseDO |
|
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sftpd |
surfactant protein D |
|
IEP |
Severe Acute Respiratory Syndrome;protein:increased expression:lung |
RGD |
PMID:19741068 |
RGD:4143520 |
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
|
|
G |
Ticam2 |
TIR domain containing adaptor molecule 2 |
|
ISS |
|
MouseDO |
|
|
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
|
|
G |
Tmprss11d |
transmembrane serine protease 11D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24227843 |
|
NCBI chr14:21,707,336...21,769,398
Ensembl chr14:21,707,336...21,769,396
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:19906920 |
RGD:4891446 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
A2m |
alpha-2-macroglobulin |
severity |
ISO |
DNA:SNPs: : mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 PMID:32747830 |
RGD:28912744, RGD:38500238 |
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
|
|
G |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
ISO |
DNA:polymorphism:cds:allele A, allele O (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:32558485 PMID:32379894 |
RGD:35668862 |
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
|
|
G |
Accs |
1-aminocyclopropane-1-carboxylate synthase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:79,805,254...79,820,830
Ensembl chr 3:79,806,587...79,820,835
|
|
G |
Ace |
angiotensin I converting enzyme |
severity no_association |
ISO |
DNA:insertion/deletion:intron 16: |
RGD |
PMID:32286246 PMID:32386188 |
RGD:30309199, RGD:30309201 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
severity |
ISO |
human gene in a mouse model CTD Direct Evidence: marker/mechanism|therapeutic DNA:insertion/deletion:intron 16: |
CTD RGD |
PMID:31996437 PMID:32061198 PMID:32081428 PMID:32092392 PMID:32117569 PMID:32129518 PMID:32132184 PMID:32133153 PMID:32142651 PMID:32149769 PMID:32201080 PMID:32203189 PMID:32275855 PMID:32286790 PMID:32404436 PMID:32380511 PMID:34668775 PMID:34668780 PMID:32220422 More...
|
RGD:30310239, RGD:151347433, RGD:151347432, RGD:32716393 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Aco2 |
aconitase 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acvr1b |
activin A receptor type 1B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:132,286,275...132,329,673
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
|
|
G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:174,754,631...174,765,136
Ensembl chr 2:174,754,633...174,765,113
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:34,920,996...35,126,465
Ensembl chr10:34,921,049...35,123,821
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
|
|
G |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
|
|
G |
Adm |
adrenomedullin |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora3 |
adenosine A3 receptor |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
|
|
G |
Adprh |
ADP-ribosylarginine hydrolase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:62,299,831...62,306,170
Ensembl chr11:62,299,793...62,306,931
|
|
G |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:90,039,760...90,475,196
Ensembl chr 9:90,039,605...90,470,958
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:9,416,842...9,428,567
Ensembl chr 3:9,416,843...9,428,371
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32048163 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
associated with hypertension |
RGD |
PMID:32228222 |
RGD:30296671 |
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahnak |
AHNAK nucleoprotein |
|
ISO |
mRNA:decreased expression:CD4+ T cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 1:205,882,223...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Aida |
axin interactor, dorsalization associated |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr13:94,940,311...94,967,920
Ensembl chr13:94,939,741...94,967,920
|
|
G |
Aimp2 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:10,701,194...10,710,772
Ensembl chr12:10,701,194...10,710,769
|
|
G |
Ajm1 |
apical junction component 1 homolog |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:8,394,942...8,401,559
Ensembl chr 3:8,392,889...8,401,321
|
|
G |
Ak2 |
adenylate kinase 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Ak4 |
adenylate kinase 4 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akap5 |
A-kinase anchoring protein 5 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
|
|
G |
Akip1 |
A-kinase interacting protein 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:163,734,730...163,743,648
Ensembl chr 1:163,734,798...163,743,648
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt3 |
AKT serine/threonine kinase 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
|
|
G |
Alb |
albumin |
severity |
ISO |
|
RGD |
PMID:32198776 PMID:32427582 |
RGD:30296673, RGD:30309200 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:20,254,196...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Alg14 |
ALG14, UDP-N-acetylglucosaminyltransferase subunit |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:209,368,285...209,445,425
Ensembl chr 2:209,368,312...209,445,431
|
|
G |
Alox15b |
arachidonate 15-lipoxygenase, type B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:53,892,496...53,901,812
Ensembl chr10:53,892,466...53,901,812
|
|
G |
Amph |
amphiphysin |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr17:45,739,385...45,982,905
Ensembl chr17:45,739,395...45,983,315
|
|
G |
Ang |
angiogenin |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:24,317,733...24,323,361
|
|
G |
Angpt2 |
angiopoietin 2 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32458111 |
RGD:32716385 |
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Angptl6 |
angiopoietin-like 6 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
|
|
G |
Ankle1 |
ankyrin repeat and LEM domain containing 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr16:18,076,413...18,082,356
Ensembl chr16:18,076,492...18,083,729
|
|
G |
Anln |
anillin, actin binding protein |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Ano5 |
anoctamin 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:101,086,490...101,187,547
Ensembl chr 1:101,087,341...101,187,555
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Ap2s1 |
adaptor related protein complex 2 subunit sigma 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:77,417,496...77,428,903
Ensembl chr 1:77,417,477...77,428,905
|
|
G |
Apol9a |
apolipoprotein L 9a |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
|
|
G |
Areg |
amphiregulin |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arhgap12 |
Rho GTPase activating protein 12 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr17:51,588,810...51,702,417
Ensembl chr17:51,588,842...51,702,080
|
|
G |
Arhgap23 |
Rho GTPase activating protein 23 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:82,437,578...82,496,846
Ensembl chr10:82,394,648...82,496,504
|
|
G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:210,060,036...210,132,572
Ensembl chr 2:210,071,199...210,132,028
|
|
G |
Arhgap31 |
Rho GTPase activating protein 31 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564
|
|
G |
Ark2c |
arkadia C-terminal like ring finger ubiquitin ligase 2C |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr18:70,984,566...71,100,836
Ensembl chr18:70,989,731...71,100,836
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Arl5b |
ADP-ribosylation factor like GTPase 5B |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr17:77,955,749...77,983,745
Ensembl chr17:77,955,818...77,979,854
|
|
G |
Arpin |
actin-related protein 2/3 complex inhibitor |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:133,864,288...133,873,124
Ensembl chr 1:133,864,265...133,873,124
|
|
G |
Arvcf |
ARVCF, delta catenin family member |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:82,588,137...82,645,805
Ensembl chr11:82,587,881...82,645,805
|
|
G |
Ascc3 |
activating signal cointegrator 1 complex subunit 3 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr20:53,510,137...53,795,446
Ensembl chr20:53,510,184...53,790,165
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617
|
|
G |
Aspm |
assembly factor for spindle microtubules |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Atp11a |
ATPase phospholipid transporting 11A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35255492 |
|
NCBI chr16:76,657,752...76,767,640
Ensembl chr16:76,657,752...76,767,640
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Atp5mc3 |
ATP synthase membrane subunit c locus 3 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp6v1f |
ATPase H+ transporting V1 subunit F |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:58,067,666...58,070,628
|
|
G |
Aurka |
aurora kinase A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Auts2 |
activator of transcription and developmental regulator AUTS2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
|
|
G |
B3gat1 |
beta-1,3-glucuronyltransferase 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:25,087,123...25,114,692
Ensembl chr 8:25,087,547...25,113,395
|
|
G |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:153,410,907...153,509,019
Ensembl chr 4:153,409,004...153,509,321
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
|
|
G |
Bag1 |
BAG cochaperone 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
|
|
G |
Batf2 |
basic leucine zipper ATF-like transcription factor 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bcl11a |
BCL11 transcription factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35255492 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl11b |
BCL11 transcription factor B |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:126,834,531...126,927,720
Ensembl chr 6:126,834,531...126,928,224
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
severity |
ISO |
associated with cardiovascular system disease;protein:increased expression:blood (human) |
RGD |
PMID:32456948 |
RGD:30309957 |
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Begain |
brain-enriched guanylate kinase-associated |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841
|
|
G |
Bet1 |
Bet1 golgi vesicular membrane trafficking protein |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 4:32,116,232...32,126,592
Ensembl chr 4:32,116,235...32,126,617
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blvra |
biliverdin reductase A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Bmal2 |
basic helix-loop-helix ARNT like 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:179,699,432...179,747,710
Ensembl chr 4:179,699,502...179,746,949
|
|
G |
Bmerb1 |
bMERB domain containing 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:1,779,834...1,946,586
Ensembl chr10:1,779,835...1,946,575
|
|
G |
Bmpr1a |
bone morphogenetic protein receptor type 1A |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr16:9,736,390...9,829,825
Ensembl chr16:9,736,630...9,780,616
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Bsg |
basigin (Ok blood group) |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:32307653 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Btk |
Bruton tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased phosphorylation:blood, monocyte (human) |
CTD RGD |
PMID:32503877 PMID:32503877 |
RGD:124713553 |
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
C15h14orf119 |
similar to human chromosome 14 open reading frame 119 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:28,146,368...28,151,422
Ensembl chr15:28,146,333...28,155,180
|
|
G |
C1galt1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 4:35,930,743...35,966,102
Ensembl chr 4:35,928,104...35,961,831
|
|
G |
C1h16orf54 |
similar to human chromosome 16 open reading frame 54 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:181,702,447...181,705,128
Ensembl chr 1:181,702,503...181,705,835
|
|
G |
C1h19orf84 |
similar to human chromosome 19 open reading frame 84 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:93,835,346...93,837,316
Ensembl chr 1:93,835,395...93,836,380
|
|
G |
C1qa |
complement C1q A chain |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C1qc |
complement C1q C chain |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C2 |
complement C2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C2h1orf162 |
similar to human chromosome 1 open reading frame 162 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:193,410,730...193,420,824
Ensembl chr 2:193,412,971...193,420,030
|
|
G |
C3 |
complement C3 |
severity |
ISO |
protein:increased expression:serum (human) DNA:SNPs: :rs1047286,rs2230203,rs2230199(human) |
RGD |
PMID:32434211 PMID:32747830 |
RGD:30310238, RGD:38500238 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C3ar1 |
complement C3a receptor 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 PMID:32407669 |
RGD:28912744 RGD:30296672 |
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
severity |
ISO |
DNA:SNP: :rs61821041(human) |
RGD |
PMID:32747830 |
RGD:38500238 |
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:42,075,717...42,111,205
|
|
G |
C4bpb |
complement component 4 binding protein, beta |
severity |
ISO |
DNA:SNP: :rs45574833(human) |
RGD |
PMID:32747830 |
RGD:38500238 |
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
|
|
G |
C5 |
complement C5 |
severity |
ISO |
protein:increased expression:plasma (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 PMID:32417135 |
RGD:28912744, RGD:30310235 |
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Cabp4 |
calcium binding protein 4 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:201,428,671...201,442,950
Ensembl chr 1:201,428,672...201,433,172
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
severity disease_progression |
ISO |
associated with diabetes mellitus |
RGD |
PMID:32198776 PMID:32345579 PMID:32220650 |
RGD:30296673, RGD:30296681, RGD:30296674 |
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Calcrl |
calcitonin receptor like receptor |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
|
|
G |
Calm2 |
calmodulin 2 |
|
ISO |
mRNA:decreased expression:CD4+ T cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:109,841,729...109,843,543
|
|
G |
Capg |
capping actin protein, gelsolin like |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capns1 |
calpain, small subunit 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
|
|
G |
Capza2 |
capping actin protein of muscle Z-line subunit alpha 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 4:45,978,142...46,014,032
Ensembl chr 4:45,977,807...46,013,864
|
|
G |
Car11 |
carbonic anhydrase 11 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:96,169,900...96,175,191
Ensembl chr 1:96,170,080...96,175,191
|
|
G |
Card6 |
caspase recruitment domain family, member 6 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:54,194,343...54,206,902
Ensembl chr 2:54,195,739...54,206,846
|
|
G |
Casp4 |
caspase 4 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Cat |
catalase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:32,860,618...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Ccdc200 |
coiled-coil domain containing 200 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:86,517,704...86,523,106
Ensembl chr10:86,517,683...86,523,038
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
severity |
ISO |
protein:increased expression:serum: CTD Direct Evidence: marker/mechanism protein:increased expression:plasma (human) protein:increased expression:serum (human) |
CTD RGD |
PMID:31986264 PMID:32416070 PMID:32696007 PMID:31986264 PMID:32360286 PMID:32427582 More...
|
RGD:30296676, RGD:38501088, RGD:30309212, RGD:30309209, RGD:30309200 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32360286 |
RGD:30309209 |
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
severity |
ISO |
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:31986264 PMID:32360286 PMID:31986264 |
RGD:30309209, RGD:30309212 |
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32360286 PMID:32696007 PMID:31986264 |
RGD:30309209, RGD:38501088, RGD:30309212 |
NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
severity |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:32427582 |
RGD:30309200 |
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
severity |
ISO |
protein:increased expression:plasma (human) mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 PMID:32360286 |
RGD:30296672, RGD:30309209 |
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccn3 |
cellular communication network factor 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccna2 |
cyclin A2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33307546 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
mRNA:decreased expression:CD4+ T cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:123,396,157...123,410,199
Ensembl chr 8:123,395,813...123,413,969
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cct8 |
chaperonin containing TCP1 subunit 8 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd180 |
CD180 molecule |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:33,855,940...33,870,046
Ensembl chr 2:33,855,991...33,899,936
|
|
G |
Cd209d |
CD209d molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35255492 |
|
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Cd247 |
Cd247 molecule |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:78,043,302...78,118,437
Ensembl chr13:78,043,307...78,122,263
|
|
G |
Cd2ap |
CD2-associated protein |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:18,086,984...18,182,199
|
|
G |
Cd4 |
Cd4 molecule |
severity |
ISO |
protein:decreased expression:blood, T cell (human) protein:decreased expression:serum, lung, T cell (human) |
RGD |
PMID:32364527 PMID:32427582 |
RGD:27226699, RGD:30309200 |
NCBI chr 4:157,668,878...157,695,366
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
mRNA:decreased expression:dendritic cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cd79a |
CD79a molecule |
|
ISO |
mRNA:decreased expression:antibody secreting B cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 1:80,493,520...80,497,936
Ensembl chr 1:80,493,581...80,497,935
|
|
G |
Cd8a |
CD8 subunit alpha |
severity exacerbates |
ISO |
protein:decreased expression:serum, lung, T cell (human) protein:increased expression:blood, T cell (mouse) mRNA:increased expression:epithelium of nasopharynx (human) |
RGD |
PMID:32427582 PMID:32991819 PMID:32898168 |
RGD:30309200, RGD:124715452, RGD:124715451 |
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
|
|
G |
Cdc20 |
cell division cycle 20 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25a |
cell division cycle 25A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:91,683,775...91,903,732
Ensembl chr13:91,684,007...91,903,732
|
|
G |
Cdc45 |
cell division cycle 45 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc6 |
cell division cycle 6 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdca2 |
cell division cycle associated 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca3 |
cell division cycle associated 3 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdca5 |
cell division cycle associated 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdca8 |
cell division cycle associated 8 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdhr1 |
cadherin-related family member 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
|
|
G |
Cdhr3 |
cadherin-related family member 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:49,641,833...49,702,016
Ensembl chr 6:49,641,813...49,702,017
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cenpf |
centromere protein F |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenpu |
centromere protein U |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
|
|
G |
Cenpw |
centromere protein W |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
|
|
G |
Cep126 |
centrosomal protein 126 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467
|
|
G |
Cep55 |
centrosomal protein 55 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Cep78 |
centrosomal protein 78 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:213,246,183...213,275,275
Ensembl chr 1:213,246,187...213,275,181
|
|
G |
Cers6 |
ceramide synthase 6 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:53,630,636...53,879,692
Ensembl chr 3:53,630,959...53,876,848
|
|
G |
Ces1d |
carboxylesterase 1D |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfh |
complement factor H |
severity |
ISO |
DNA:SNP: : |
RGD |
PMID:32747830 |
RGD:38500238 |
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chic1 |
cysteine-rich hydrophobic domain 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr X:68,362,001...68,406,155
Ensembl chr X:68,361,969...68,437,887
|
|
G |
Chmp5 |
charged multivesicular body protein 5 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 5:56,081,385...56,098,529
Ensembl chr 5:56,081,343...56,098,529
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:116,715,286...116,837,223
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chst13 |
carbohydrate sulfotransferase 13 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:122,824,712...122,837,935
Ensembl chr 4:122,824,022...122,838,019
|
|
G |
Cir1 |
corepressor interacting with RBPJ, 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 3:58,159,418...58,188,719
Ensembl chr 3:58,158,951...58,188,789
|
|
G |
Cit |
citron rho-interacting serine/threonine kinase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:40,603,073...40,764,846
Ensembl chr12:40,605,563...40,763,860
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Clcn4 |
chloride voltage-gated channel 4 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr X:23,729,194...23,795,391
Ensembl chr X:23,729,338...23,793,238
|
|
G |
Cldn7 |
claudin 7 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
|
|
G |
Cldnd2 |
claudin domain containing 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:93,848,533...93,851,693
Ensembl chr 1:93,848,533...93,851,217
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Clec12b |
C-type lectin domain family 12, member B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:162,827,462...162,843,821
Ensembl chr 4:162,827,462...162,838,946
|
|
G |
Clec1b |
C-type lectin domain family 1, member B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291
|
|
G |
Clspn |
claspin |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Clta |
clathrin, light chain A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:58,244,253...58,263,480
Ensembl chr 5:58,245,442...58,263,472
|
|
G |
Cmtm2b |
CKLF-like MARVEL transmembrane domain containing 2B |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr19:640,837...651,872
Ensembl chr19:640,824...651,939
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Colgalt2 |
collagen beta(1-O)galactosyltransferase 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:64,523,641...64,628,295
Ensembl chr13:64,523,658...64,627,549
|
|
G |
Commd9 |
COMM domain containing 9 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:88,175,909...88,190,427
Ensembl chr 3:88,175,987...88,190,439
|
|
G |
Copb2 |
COPI coat complex subunit beta 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:99,161,324...99,183,452
Ensembl chr 8:99,161,350...99,185,197
|
|
G |
Coq5 |
coenzyme Q5, methyltransferase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:41,316,922...41,333,855
Ensembl chr12:41,316,748...41,333,848
|
|
G |
Coro2b |
coronin 2B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:62,906,861...63,017,295
Ensembl chr 8:62,906,867...63,017,302
|
|
G |
Coro6 |
coronin 6 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cpa3 |
carboxypeptidase A3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:102,712,483...102,744,219
Ensembl chr 2:102,712,589...102,744,203
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
|
|
G |
Crip2 |
cysteine-rich protein 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065
|
|
G |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:93,708,786...93,769,617
Ensembl chr 9:93,708,684...93,769,402
|
|
G |
Crp |
C-reactive protein |
severity disease_progression |
ISO |
protein:increased expression:serum (human) CTD Direct Evidence: marker/mechanism associated with hyperglycemia;protein:increased expression:serum (human) associated with cardiovascular system disease;protein:increased expression:blood (human) protein:increased expression:plasma (human) associated with diabetes mellitus |
CTD RGD |
PMID:32534021 PMID:32125452 PMID:32406594 PMID:32434211 PMID:32456948 PMID:32181911 PMID:32417135 PMID:32365221 PMID:32427582 PMID:32345579 PMID:32198776 PMID:32227274 More...
|
RGD:27095965, RGD:32698682, RGD:30310238, RGD:30309957, RGD:30310230, RGD:30310235, RGD:30310229, RGD:30309200, RGD:30296681, RGD:30296673, RGD:27226695 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Csf1 |
colony stimulating factor 1 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32360286 PMID:32696007 |
RGD:30309209, RGD:38501088 |
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf2 |
colony stimulating factor 2 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:31986264 |
RGD:30309212 |
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
severity |
ISO |
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:31986264 PMID:32360286 PMID:31986264 |
RGD:30309209, RGD:30309212 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cst7 |
cystatin F |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
|
|
G |
Ctnnd1 |
catenin delta 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Ctsb |
cathepsin B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsl |
cathepsin L |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Ctsz |
cathepsin Z |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma (human) |
CTD RGD |
PMID:31986264 PMID:32427582 PMID:32696007 PMID:31986264 PMID:32360286 |
RGD:30309200, RGD:38501088, RGD:30309212, RGD:30309209 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl16 |
C-X-C motif chemokine ligand 16 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:32416070 |
RGD:30296676 |
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
|
|
G |
Cxcl17 |
C-X-C motif chemokine ligand 17 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:80,984,751...80,996,842
Ensembl chr 1:80,984,964...80,996,726
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:32416070 |
RGD:30296676 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr14:17,310,089...17,312,303
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
severity |
ISO |
protein:increased expression:serum: protein:increased expression:plasma (human) |
RGD |
PMID:32416070 PMID:32696007 PMID:32360286 |
RGD:30296676, RGD:38501088, RGD:30309209 |
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 9:75,768,124...75,771,122
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 PMID:32407669 |
RGD:28912744 RGD:30296672 |
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
mRNA:decreased expression:memory B cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cybrd1 |
cytochrome b reductase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:55,934,874...55,962,132
Ensembl chr 3:55,934,874...55,962,108
|
|
G |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:106,710,924...106,799,393
Ensembl chr 1:106,711,016...106,799,386
|
|
G |
Dapp1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 2:226,425,890...226,475,445
Ensembl chr 2:226,425,898...226,475,423
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Dennd1b |
DENN domain containing 1B |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr13:50,545,324...50,772,922
Ensembl chr13:50,545,836...50,770,601
|
|
G |
Depdc1b |
DEP domain containing 1B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G |
Dera |
deoxyribose-phosphate aldolase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:170,663,646...170,742,469
Ensembl chr 4:170,663,665...170,758,865
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:121,344,637...121,368,853
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Dlgap5 |
DLG associated protein 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Draxin |
dorsal inhibitory axon guidance protein |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:158,530,149...158,563,457
Ensembl chr 5:158,530,342...158,564,483
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr10:16,680,489...16,683,276
|
|
G |
Dusp2 |
dual specificity phosphatase 2 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
|
|
G |
Dusp7 |
dual specificity phosphatase 7 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:41,312,367...41,314,742
Ensembl chr12:41,312,367...41,314,741
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
Eaf2 |
ELL associated factor 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
|
|
G |
Ebf4 |
EBF family member 4 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:117,498,186...117,566,566
Ensembl chr 3:117,498,319...117,566,566
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
ISO |
mRNA:decreased expression:antibody secreting B cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
mRNA:decreased expression:antibody secreting B cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Efcab2 |
EF-hand calcium binding domain 2 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr13:90,152,002...90,237,918
Ensembl chr13:90,152,185...90,238,218
|
|
G |
Efna5 |
ephrin A5 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:102,316,753...102,595,480
Ensembl chr 9:102,320,295...102,597,413
|
|
G |
Egr3 |
early growth response 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
|
|
G |
Eif4e3 |
eukaryotic translation initiation factor 4E family member 3 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 4:132,258,502...132,301,808
Ensembl chr 4:132,258,502...132,301,808
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Elane |
elastase, neutrophil expressed |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32696007 |
RGD:38501088 |
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
|
|
G |
Ell2 |
elongation factor for RNA polymerase II 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase family member 5 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:16,910,187...16,917,633
Ensembl chr 9:16,910,831...16,917,480
|
|
G |
Ephb1 |
Eph receptor B1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
|
|
G |
Ephb2 |
Eph receptor B2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Epsti1 |
epithelial stromal interaction 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 PMID:32407669 |
RGD:28912744 RGD:30296672 |
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
|
|
G |
Eral1 |
Era-like 12S mitochondrial rRNA chaperone 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:62,961,729...62,968,766
Ensembl chr10:62,961,730...62,968,994
|
|
G |
Eri2 |
ERI1 exoribonuclease family member 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:174,140,831...174,168,757
Ensembl chr 1:174,141,993...174,168,665
|
|
G |
Erlin1 |
ER lipid raft associated 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:242,921,147...242,956,472
Ensembl chr 1:242,921,152...242,956,394
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Esrp2 |
epithelial splicing regulatory protein 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726
|
|
G |
Exo1 |
exonuclease 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
F2 |
coagulation factor II |
severity disease_progression |
ISO |
associated with diabetes mellitus |
RGD |
PMID:32198776 PMID:32350161 PMID:32345579 PMID:32302954 |
RGD:30296673, RGD:30309962, RGD:30296681, RGD:30296679 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F3 |
coagulation factor III, tissue factor |
severity |
ISO |
DNA:SNP: : (rs72729504) (human) |
RGD |
PMID:32198776 PMID:32747830 |
RGD:30296673, RGD:38500238 |
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F5 |
coagulation factor V |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:76,513,463...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
F8 |
coagulation factor VIII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35255492 |
|
NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam131b |
family with sequence similarity 131, member B |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:71,201,037...71,210,292
Ensembl chr 4:71,201,038...71,210,228
|
|
G |
Fam169a |
family with sequence similarity 169, member A |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:28,384,162...28,441,361
Ensembl chr 2:28,383,784...28,438,910
|
|
G |
Fam20c |
FAM20C, golgi associated secretory pathway kinase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:15,826,864...15,885,423
Ensembl chr12:15,826,871...15,884,543
|
|
G |
Fam72a |
family with sequence similarity 72, member A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:42,968,409...42,978,976
Ensembl chr13:42,967,578...42,984,208
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr19:52,710,003...52,722,591
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fcmr |
Fc mu receptor |
|
ISO |
mRNA:decreased expression:memory B cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
|
|
G |
Fcrl5 |
Fc receptor-like 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:172,881,763...172,912,912
Ensembl chr 2:172,881,448...172,913,148
|
|
G |
Fcrl6 |
Fc receptor-like 6 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:85,062,709...85,072,308
Ensembl chr13:85,066,694...85,072,600
|
|
G |
Fer1l4 |
fer-1-like family member 4 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:144,536,099...144,571,634
Ensembl chr 3:144,536,099...144,571,634
|
|
G |
Fgd2 |
FYVE, RhoGEF and PH domain containing 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:31986264 |
RGD:30309212 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr14:1,009,863...1,022,620
Ensembl chr14:1,009,786...1,021,928
|
|
G |
Fgl2 |
fibrinogen-like 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fh |
fumarate hydratase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fhip1a |
FHF complex subunit HOOK interacting protein 1A |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:171,016,951...171,265,715
Ensembl chr 2:171,021,246...171,265,848
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fkbp9 |
FKBP prolyl isomerase 9 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:86,106,256...86,156,723
Ensembl chr 4:86,106,282...86,156,721
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Flt3 |
Fms related receptor tyrosine kinase 3 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:7,623,658...7,699,474
Ensembl chr12:7,623,930...7,699,474
|
|
G |
Flvcr2 |
FLVCR heme transporter 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:105,408,355...105,472,355
Ensembl chr 6:105,408,339...105,472,353
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxn2 |
forkhead box N2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 6:6,018,653...6,065,216
Ensembl chr 6:6,018,879...6,064,278
|
|
G |
Frrs1 |
ferric-chelate reductase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:204,820,898...204,881,487
Ensembl chr 2:204,823,025...204,895,540
|
|
G |
Fth1 |
ferritin heavy chain 1 |
severity |
ISO |
protein:increased expression:serum (human) associated with hyperglycemia;protein:increased expression:serum (human) |
RGD |
PMID:32365221 PMID:32406594 |
RGD:30310229, RGD:32698682 |
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
severity |
ISO |
protein:increased expression:serum (human) associated with hyperglycemia;protein:increased expression:serum (human) |
RGD |
PMID:32365221 PMID:32406594 |
RGD:30310229, RGD:32698682 |
NCBI chr 1:95,936,390...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Fuca2 |
alpha-L-fucosidase 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776
|
|
G |
Fut2 |
fucosyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35255492 |
|
NCBI chr 1:96,119,549...96,139,567
Ensembl chr 1:96,119,371...96,140,360
|
|
G |
Fzd2 |
frizzled class receptor 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
Fzd5 |
frizzled class receptor 5 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:66,117,370...66,119,127
Ensembl chr 9:66,113,112...66,121,457
|
|
G |
G0s2 |
G0/G1switch 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pc3 |
glucose 6 phosphatase catalytic subunit 3 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:87,146,987...87,151,223
Ensembl chr10:87,146,901...87,151,221
|
|
G |
Gaa |
alpha glucosidase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
|
|
G |
Gabarapl1 |
GABA type A receptor associated protein like 1 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 PMID:32407669 |
RGD:30296672 RGD:32716422 |
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Galk1 |
galactokinase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337
|
|
G |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
|
|
G |
Gask1b |
golgi associated kinase 1B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gbgt1 |
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group) |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:11,826,131...11,829,745
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gdf11 |
growth differentiation factor 11 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:1,311,732...1,325,211
Ensembl chr 7:1,311,732...1,320,725
|
|
G |
Gfap |
glial fibrillary acidic protein |
disease_progression |
ISO |
protein:increased expression:plasma (human) protein:increased expression:serum (human) |
RGD |
PMID:32546655 PMID:33743046 |
RGD:127284882, RGD:127284892 |
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Gimap4 |
GTPase, IMAP family member 4 |
|
ISO |
mRNA:decreased expression:CD4+ T cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 4:77,636,401...77,643,315
Ensembl chr 4:77,636,401...77,643,306
|
|
G |
Gimap7 |
GTPase, IMAP family member 7 |
|
ISO |
mRNA:decreased expression:CD4+ T cells (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr 4:77,670,522...77,674,692
Ensembl chr 4:77,670,367...77,675,272
|
|
G |
Gldc |
glycine decarboxylase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:227,883,247...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Gldn |
gliomedin |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:54,679,015...54,723,198
Ensembl chr 8:54,679,119...54,723,196
|
|
G |
Gli1 |
GLI family zinc finger 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Glmp |
glycosylated lysosomal membrane protein |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960
|
|
G |
Glrx |
glutaredoxin |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Gnpda1 |
glucosamine-6-phosphate deaminase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr18:30,165,435...30,177,462
Ensembl chr18:30,165,427...30,177,486
|
|
G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Gpnmb |
glycoprotein nmb |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
|
|
G |
Gpr68 |
G protein-coupled receptor 68 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:120,135,620...120,166,089
Ensembl chr 6:120,135,436...120,166,089
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr14:86,495,054...86,602,815
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grhpr |
glyoxylate and hydroxypyruvate reductase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 5:59,234,179...59,243,614
Ensembl chr 5:59,234,192...59,243,603
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
severity |
ISO |
DNA:deletion: |
RGD |
PMID:32454047 |
RGD:30309963 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Gzmb |
granzyme B |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32696007 |
RGD:38501088 |
NCBI chr15:30,343,361...30,346,792
Ensembl chr15:30,173,603...30,346,814
|
|
G |
H1f0 |
H1.0 linker histone |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H1f10 |
H1.10 linker histone |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:120,440,515...120,444,705
Ensembl chr 4:120,440,870...120,441,448
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hccs |
holocytochrome c synthase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr X:24,932,943...24,942,376
Ensembl chr X:24,933,002...24,942,366
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33617879 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hdlbp |
high density lipoprotein binding protein |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
|
|
G |
Heatr4 |
HEAT repeat containing 4 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:103,574,360...103,611,578
Ensembl chr 6:103,574,366...103,612,100
|
|
G |
Hebp1 |
heme binding protein 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:167,974,318...168,003,859
Ensembl chr 4:167,974,319...168,003,854
|
|
G |
Hexb |
hexosaminidase subunit beta |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hgf |
hepatocyte growth factor |
severity |
ISO |
protein:increased expression:plasma (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 PMID:32360286 |
RGD:28912744, RGD:30309209 |
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hjurp |
Holliday junction recognition protein |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:88,853,379...88,867,730
Ensembl chr 9:88,853,386...88,867,728
|
|
G |
Hk1 |
hexokinase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr20:30,230,488...30,332,161
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hp |
haptoglobin |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hrh4 |
histamine receptor H4 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr X:21,089,152...21,091,597
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Hvcn1 |
hydrogen voltage-gated channel 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr12:34,341,673...34,370,010
Ensembl chr12:34,335,190...34,370,141
|
|
G |
Icam5 |
intercellular adhesion molecule 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35255492 |
|
NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Ier2 |
immediate early response 2 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
|
|
G |
Ier3 |
immediate early response 3 |
|
ISO |
mRNA:increased expression:CD14++ monocytes (human) |
RGD |
PMID:32377375 |
RGD:32716422 |
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi27l2b |
interferon, alpha-inducible protein 27 like 2B |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
|
|
G |
Ifi44 |
interferon-induced protein 44 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
|
|
G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:232,152,038...232,154,103
Ensembl chr 1:232,127,170...232,154,435
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
severity |
ISO |
DNA:SNP: (rs12252)(human) mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 PMID:32348495 |
RGD:30296672, RGD:30296684 |
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
|
|
G |
Ifnar2 |
interferon alpha and beta receptor subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33307546 |
|
NCBI chr11:30,613,576...30,645,958
Ensembl chr11:30,613,767...30,668,124
|
|
G |
Ifnb1 |
interferon beta 1 |
treatment |
ISO |
|
RGD |
PMID:32401715 |
RGD:30296675 |
NCBI chr 5:103,020,969...103,021,523
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:31986264 PMID:32696007 |
RGD:30309212, RGD:38501088 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifngr2 |
interferon gamma receptor 2 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr11:30,779,733...30,798,005
Ensembl chr11:30,779,733...30,798,005
|
|
G |
Ifnl1 |
interferon, lambda 1 |
ameliorates |
ISO |
human protein in a mouse model |
RGD |
PMID:32854108 |
RGD:126848773 |
NCBI chr 1:83,798,651...83,800,297
Ensembl chr 1:83,798,703...83,800,235
|
|
G |
Iftap |
intraflagellar transport associated protein |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
IgG-2a |
gamma-2a immunoglobulin heavy chain |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
|
|
G |
Igh-6-ps1 |
immunoglobulin heavy chain 6, pseudogene 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 6:136,154,202...136,187,939
Ensembl chr 6:136,187,348...136,187,728
|
|
G |
Ighg1 |
immunoglobulin heavy constant gamma 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
Ensembl chr 6:132,389,370...132,393,397
|
|
G |
Igkc |
immunoglobulin kappa constant |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
|
|
G |
Igkvl-ps13 |
immunoglobulin kappa variable like, pseudogene 13 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 4:96,968,574...96,969,477
|
|
G |
Igll1 |
immunoglobulin lambda-like polypeptide 1 |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr11:84,138,847...84,142,238
Ensembl chr11:84,138,910...84,142,216
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:32228226 |
RGD:28912744 |
NCBI chr 9:71,042,440...71,191,296
Ensembl chr 9:71,042,440...71,190,867
|
|
G |
Il10 |
interleukin 10 |
severity |
ISO |
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism associated with cardiovascular system disease;protein:increased expression:blood (human) protein:increased expression:serum (human) |
CTD RGD |
PMID:31986264 PMID:32161940 PMID:31986264 PMID:32696007 PMID:32456948 PMID:32365221 More...
|
RGD:30309212, RGD:38501088, RGD:30309957, RGD:30310229 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
|
ISO |
mRNA:decreased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il10rb |
interleukin 10 receptor subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35255492 |
|
NCBI chr11:30,646,494...30,668,081
Ensembl chr11:30,652,096...30,668,074
|
|
G |
Il13 |
interleukin 13 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32360286 PMID:31986264 |
RGD:30309209, RGD:30309212 |
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il17a |
interleukin 17A |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:31986264 |
RGD:30309212 |
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:32360286 PMID:32696007 |
RGD:30309209, RGD:38501088 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
severity |
ISO |
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:32171193 PMID:31986264 |
RGD:30309212 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
severity |
ISO |
protein:increased expression:serum: protein:increased expression:plasma (human) |
RGD |
PMID:32416070 PMID:31986264 PMID:32360286 |
RGD:30296676, RGD:30309212, RGD:30309209 |
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
severity |
ISO |
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:31986264 PMID:31986264 PMID:32696007 |
RGD:30309212, RGD:38501088 |
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
severity |
ISO |
protein:increased expression:serum (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:32026671 PMID:32161940 PMID:32365221 PMID:32164089 PMID:32297828 |
RGD:30310229, RGD:36049814, RGD:32716368 |
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
severity |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:32297828 |
RGD:32716368 |
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
severity |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:32297828 |
RGD:32716368 |
NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823
|
|
G |
Il4 |
interleukin 4 |
severity |
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:31986264 |
RGD:30309212 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
mRNA:decreased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32228226 PMID:32407669 |
RGD:28912744 RGD:30296672 |
NCBI chr 4:139,630,652...139,664,593
Ensembl chr 4:139,632,066...139,668,544
|
|
G |
Il6 |
interleukin 6 |
severity disease_progression |
ISO |
protein:increased expression:serum (human) CTD Direct Evidence: marker/mechanism protein:increased expression:plasma (human) associated with cardiovascular system disease;protein:increased expression:blood (human) associated with diabetes mellitus protein:increased expression:serum: |
CTD RGD |
PMID:32026671 PMID:32161940 PMID:32171193 PMID:32534021 PMID:32125452 PMID:32696007 PMID:32164089 PMID:32297828 PMID:32434211 PMID:32456948 PMID:32181911 PMID:32365221 PMID:31986264 PMID:32407836 PMID:32427582 PMID:32345579 PMID:32416070 PMID:32227274 More...
|
RGD:27095965, RGD:38501088, RGD:36049814, RGD:32716368, RGD:30310238, RGD:30309957, RGD:30310230, RGD:30310229, RGD:30309212, RGD:30309206, RGD:30309200, RGD:30296681, RGD:30296676, RGD:27226695 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7 |
interleukin 7 |
severity |
ISO |
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:31986264 PMID:31986264 |
RGD:30309212 |
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
| |